semaglutide gonzales Weight Loss Semaglutide Safety Questions

A smaller analysis, also published in JAMA Neurology, found that GLP-1 drugs as well as a similar class of diabetes medications known as SGLT2 inhibitors may have benefits for brain health with regard to Alzheimers disease and related dementias

J Am Heart Association 12:e028409 Aggarwal R, Ostrominski JW, Vaduganathan M (2024) Prevalence of cardiovascular-kidney-metabolic syndrome stages in US adults, 20112020

A 2-year clinical study in 1991 used low-dose IM DFO (125 mg b.i.d., 5 days/week) in AD patients, which showed a significantly slower (50%) decline in daily living skills, suggesting a disease-slowing effect (Crapper McLachlan et al., 1991)

Drug Metab Rev

This is the concern that keeps me up at night as a clinician, and its the question every Medicare patient considering this program should ask